Our newest paper is out in NCB. @jrwconway.bsky.social‬ designed a new FRET reporter, Illusia, to show the importance of integrin β1 phosphorylation dynamics in 3D invasion! Video: TNBC cells expressing Illusia with a Src (Saracatinib) or SHP2 (SHP099) inhibitor. www.nature.com/articles/s41...

New paper from @ivaskalab.bsky.social out now! 🍾 Watch how cancer cell adhesion dynamics are disrupted by inhibiting the phosphatase Shp2 - key to integrin β1 phosphorylation. Blocking Shp2 impairs adhesion and reduces invasion potential. 🎥👇 Read more at: www.nature.com/articles/s41...

Can't wait to be in Italy for GRS/GRC...! 🥶
Fibronectin, Integrins and Related Molecules
www.grc.org/fibronectin-...
I'll present our preprint and more on extravasation of PDACs. :)

We wrote a small Viewpoint for Molecular Oncology with
@follainga.bsky.social

@omkarjoshi.bsky.social

Michal Dibus

via EACR
@helloeacr.bsky.social

Time, the final frontier
febs.onlinelibrary.wiley.com/doi/full/10....

Hope you find it interesting

Trying something new: For our recent preprint:

Fast label-free live imaging reveals key roles of flow dynamics and CD44-HA interaction in cancer cell arrest on endothelial monolayers

www.biorxiv.org/content/10.1...

I made an online presentation:
www.beautiful.ai/player/-ODGe...

Introductory post on 🦋! We're a research group headed by Prof. Johanna Ivaska interested in understanding how integrins contribute to every step of cancer progression. We're located at the Turku Bioscience Center in Turku, Finland! Find out more about us and our interests here: ivaskalab.utu.fi